Zyrtec-D - Risks of posterior reversible encephalopathy syndrome and reversible cerebral vasoconstriction syndrome associated with the use of pseudoephedrine

Drug safety news regarding pseudoephedrine - GMDP Academy

Neuroimaging findings of posterior reversible encephalopathy syndrome (PRES) following haematopoietic stem cell transplantation in paediatric recipients, BMC Pediatrics

药物办公室– 药剂业界主页

Cerebrovascular Dysregulation: Posterior Reversible Encephalopathy Syndrome and Reversible Cerebral Vasoconstriction Syndrome.

PDF) Decongestant use and the risk of myocardial infarction and stroke: a case-crossover study

UW Step 2 CK Peds-Update 1, PDF, Puberty

PDF) Bromocriptine-associated headache: possible life-threatening sympathomimetic interaction

藥物辦公室- 消費者主頁

Drug Office - Pharmaceutical Trade Homepage

Posterior reversible encephalopathy syndrome: A review with emphasis on neuroimaging characteristics - ScienceDirect

PDF) Decongestant use and the risk of myocardial infarction and stroke: a case-crossover study

Otologic and Neurotologic Disorders in Pregnancy

Drug Office - Pharmaceutical Trade Homepage

Cerebrovascular Dysregulation: Posterior Reversible Encephalopathy Syndrome and Reversible Cerebral Vasoconstriction Syndrome.